Horizon Europe is the European Union (EU) funding programme for the period 2021 – 2027, which targets the sectors of research and innovation. The programme’s budget is around € 95.5 billion, of which € 5.4 billion is from NextGenerationEU to stimulate recovery and strengthen the EU’s resilience in the future, and € 4.5 billion is additional aid.
The scope of this topic is set by the definitions provided by ‘The international classification of diseases’ – World Health Organization (WHO) ICD11 under ‘6A00: Disorders of intellectual development’ and under ‘20: Developmental anomalies’ including disorders of intellectual development, such as ‘LD40: Complete trisomies of the autosomes’ and ‘LD90: Conditions with disorders of intellectual development as a relevant clinical feature’.
Moreover, the three types of autism with disorders of intellectual development (6A02.1, 6A02.3 and 6A02.5) under ‘6A02: Autism spectrum disorder’ are also within the scope of this topic.
The focus of this topic is human-centred on the persons with long-term intellectual disabilities and their formal and informal carers, including families.
The life expectancy of persons with intellectual disabilities has increased in the last 20 years, which makes it even more important to analyse the role of their families acting as informal carers (e.g. ageing parents).
Innovative solutions are needed to provide novel medicines, diagnoses, treatments, protocols, technologies or digital solutions, etc. that can help in an early stage to prevent the worsening of the intellectual disability and/or related co-morbidities, reverse or reduce it, and to improve the autonomy of affected persons and relieve their carers.
Research actions under this topic should address several of the following areas:
Applicants are encouraged to include patients, their families and carers in the different stages of the research. Likewise, it is encouraged to involve stakeholders from within and outside the intellectual disabilities sector, in particular policymakers and public authorities, citizens and civil society organisations, end-users and service providers.
All projects funded under this topic are encouraged to participate in networking and joint activities, as appropriate. These networking and joint activities could, for example, involve the participation in joint workshops, the exchange of knowledge, the development and adoption of best practices, or joint communication activities. Therefore, proposals are expected to include a budget for the attendance to regular joint meetings and may consider covering the costs of any other potential joint activities without the prerequisite to detail concrete joint activities at this stage. The details of these joint activities will be defined during the grant agreement preparation phase.
100%
Expected EU contribution per project: between €6.00 and €8.00 million.
In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding.
If projects use satellite-based earth observation, positioning, navigation and/or related timing data and services, beneficiaries must make use of Copernicus and/or Galileo/EGNOS (other data and services may additionally be used).
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects.
Research and Innovation Foundation
29a Andrea Michalakopoulou, 1075 Nicosia,
P.B. 23422, 1683 Nicosia
Telephone: +357 22205000
Fax: +357 22205001
Email: support@research.org.cy
Website: https://www.research.org.cy/en/
Contact Person:
George Christou
Scientific Officer
Email: gchristou@research.org.cy